Human medicines European public assessment report (EPAR): Fluad, influenza vaccine (surface antigen, inactivated, adjuvanted), Date of authorisation: 15/11/2024, Revision: 2, Status: Authorised
Advice on the influenza virus on request from the Medical Device Coordination Group
Minutes of the HMPC meeting 4-6 May 2026
PSUSA/00002798/202411
Referral: Veterinary medicinal products containing amoxicillin, amoxicillin Article 141(1)(i) procedures Under evaluation, 17/07/2026
Tavneos
Orphan designation: infliximab Treatment of Kawasaki disease, 20/05/2026 Positive
Orphan designation: allogeneic human induced pluripotent stem cell-derived photoreceptor precursor cells Treatment of non-syndromic inherited retinal dystrophies of the rod-dominant phenotype, 20/05/2026 Positive
Orphan designation: allogeneic human Wharton's jelly-derived mesenchymal stem cells Treatment of Charcot-Marie-Tooth disease, 20/05/2026 Positive
Orphan designation: peptide-oligonucleotide conjugate against CNOT3 mRNA Treatment of inherited retinal dystrophies due to mutation in the PRPF31 gene, 20/05/2026 Positive